MedTrace Logo

Assessing Safety of Cervical Spine Fusion With NMP®

NCT07245940 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-11-24

No results posted yet for this study

Summary

The goal of this retrospective chart review study is to assess safety of NMP® in the treatment of cervical spine degenerative conditions by assessing the incidence and nature of AEs in follow-up (minimum of 90 days and up to 2 year post-operatively) as well as reoperation rates.

Conditions

  • Degenerative Disc Disease
  • Degenerative Spondylolisthesis
  • Spinal Stenosis Cervical

Interventions

BIOLOGICAL

Natural Matrix Protein (NMP) Fibers

Human bone allograft

PROCEDURE

Cervical interbody fusion

Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between C2 and T1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.

Sponsors & Collaborators

  • Red Rock Regeneration Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-06-01
Completion
2026-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07245940 on ClinicalTrials.gov